Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide-Reference-Cited by-同舟云学术

Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide

Published:2010-01 Issue:1 Volume:51 Page:74-80
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Baranowski Marcin,Blachnio-Zabielska Agnieszka,Hirnle Tomasz,Harasiuk Dorota,Matlak Krzysztof,Knapp Malgorzata,Zabielski Piotr,Gorski Jan

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference35 articles.

1. Lipotoxicity in the heart;Borradaile;Curr. Hypertens. Rep.,2005

2. Adaptation and maladaptation of the heart in obesity;Harmancey;Hypertension.,2008

3. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms;Young;Circulation.,2002

4. Lipids in the heart: a source of fuel and a source of toxins;Park;Curr. Opin. Lipidol.,2007

5. A novel mouse model of lipotoxic cardiomyopathy;Chiu;J. Clin. Invest.,2001

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage;International Journal of Molecular Sciences;2023-11-23

2. Metabolismo de los esfingolípidos y su relación con las enfermedades cardiovasculares, renales y metabólicas;Archivos de Cardiología de México;2023-04-11

3. Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats;International Journal of Molecular Sciences;2022-03-07

4. Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications;Theranostics;2022

5. Neutral sphingomyelinase‐2 and cardiometabolic diseases;Obesity Reviews;2021-03-18